Rapamycin-modified CD169low/-tolDC promotes skin graft survival in mice via IL-10+Breg
{{output}}
Skin allografts are prone to rejection because of their high immunogenicity. By achieving immune tolerance, the long-term survival of skin allografts can be extended without the need for immunosuppressants or with only short-term low-dose dependency. Tolerogen... ...